Sex Differences in Leptin Levels in Children and Adolescents with Normal Weight and Overweight/Obesity Across Pubertal Stages: A Systematic Review and Meta-analysis - Scorecard - MDSpire

Sex Differences in Leptin Levels in Children and Adolescents with Normal Weight and Overweight/Obesity Across Pubertal Stages: A Systematic Review and Meta-analysis

  • By

  • Rutuja Dhamale

  • Alejandra V Rodríguez Rondón

  • Eline E P L van der Walle

  • Erica L T van den Akker

  • Jenny A Visser

  • November 15, 2025

  • 0 min

Share

Clinical Scorecard: Sex-Based Variations in Leptin Concentrations Among Normal Weight and Overweight/Obese Children and Adolescents Throughout Puberty: A Comprehensive Review and Meta-Analysis

At a Glance

CategoryDetail
ConditionLeptin level variations and their relationship with puberty and obesity in children and adolescents
Key MechanismsLeptin produced by adipose tissue regulates energy homeostasis and acts as a permissive factor for puberty onset via stimulation of the hypothalamus-pituitary-gonadal axis, interacting with kisspeptin and other neuropeptides
Target PopulationChildren and adolescents aged 5 to 19 years with normal weight and overweight/obesity
Care SettingPediatric endocrinology and obesity management settings

Key Highlights

  • Girls with normal weight have consistently higher leptin levels than boys across all pubertal stages.
  • In overweight/obese children, sex differences in leptin levels are diminished during prepubertal and pubertal stages but reappear postpubertally.
  • Obesity disrupts the typical sex-specific leptin pattern, suggesting leptin alone does not explain accelerated puberty in obese girls.

Guideline-Based Recommendations

Diagnosis

  • Assess leptin levels alongside BMI-SDS and pubertal staging (Tanner stages) to evaluate pubertal development and obesity status.
  • Consider sex-specific differences when interpreting leptin concentrations in pediatric patients.

Management

  • Monitor body composition and leptin levels in children with overweight/obesity to understand pubertal progression.
  • Address obesity early to potentially modulate its impact on pubertal timing, especially in girls.

Monitoring & Follow-up

  • Track pubertal development using Tanner staging and BMI-SDS in conjunction with leptin measurements.
  • Observe sex-specific hormonal changes, including testosterone and estrogen levels, to contextualize leptin data.

Risks

  • Obesity-related alterations in leptin and sex steroid levels may contribute to abnormal pubertal timing and metabolic complications.
  • Low leptin levels (e.g., in congenital deficiency or anorexia nervosa) can cause hypogonadotropic hypogonadism and delayed puberty.

Patient & Prescribing Data

Children and adolescents aged 5-19 years with normal weight or overweight/obesity undergoing pubertal development

Leptin levels reflect nutritional status and adiposity but are insufficient alone to explain sex differences in pubertal timing; combined evaluation with other neuroendocrine factors is recommended.

Clinical Best Practices

  • Use sex- and age-specific BMI percentiles and BMI-SDS for accurate classification of overweight and obesity in pediatric patients.
  • Incorporate leptin measurement as part of a comprehensive assessment of pubertal development and metabolic status.
  • Recognize that obesity may mask typical sex differences in leptin levels during puberty, necessitating multifactorial evaluation.
  • Consider the role of kisspeptin and other neuroendocrine regulators alongside leptin in managing pubertal disorders.
  • Educate families about the impact of obesity on puberty and metabolic health to encourage early lifestyle interventions.

References

Original Source(s)

Related Content